What is the share price of Astec Lifesciences Ltd (ASTEC) today?
The share price of ASTEC as on 10th March 2025 is ₹710.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Astec Lifesciences Ltd (ASTEC) share?
The past returns of Astec Lifesciences Ltd (ASTEC) share are- Past 1 week: 3.78%
- Past 1 month: -16.51%
- Past 3 months: -34.37%
- Past 6 months: -40.84%
- Past 1 year: -32.86%
- Past 3 years: -54.26%
- Past 5 years: 48.18%
What are the peers or stocks similar to Astec Lifesciences Ltd (ASTEC)?
The peers or stocks similar to Astec Lifesciences Ltd (ASTEC) include:What is the dividend yield % of Astec Lifesciences Ltd (ASTEC) share?
The current dividend yield of Astec Lifesciences Ltd (ASTEC) is 0.21.What is the market cap of Astec Lifesciences Ltd (ASTEC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astec Lifesciences Ltd (ASTEC) is ₹1394.17 Cr as of 10th March 2025.What is the 52 week high and low of Astec Lifesciences Ltd (ASTEC) share?
The 52-week high of Astec Lifesciences Ltd (ASTEC) is ₹1474.40 and the 52-week low is ₹647.50.What is the PE and PB ratio of Astec Lifesciences Ltd (ASTEC) stock?
The P/E (price-to-earnings) ratio of Astec Lifesciences Ltd (ASTEC) is -29.70. The P/B (price-to-book) ratio is 3.77.Which sector does Astec Lifesciences Ltd (ASTEC) belong to?
Astec Lifesciences Ltd (ASTEC) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.How to buy Astec Lifesciences Ltd (ASTEC) shares?
You can directly buy Astec Lifesciences Ltd (ASTEC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Astec Lifesciences Ltd
ASTECAstec Lifesciences Ltd
ASTEC
MaterialsFertilizers & Agro Chemicals
SmallcapWith a market cap of ₹1,394 cr, stock is ranked 1,204
High RiskStock is 3.23x as volatile as Nifty
710.900.00% (+0.00)
710.900.00% (+0.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -11.65 | 3.77 | 0.21% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 28.01 | 3.18 | 1.49% |
Forecast & Ratings
Detailed Forecast 100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Astec LifeSciences Limited is a holding company. The Company is a producer of agrochemicals and pharmaceutical intermediates.
Peers
Compare with peersCOROMANDEL
PE Ratio
31.38
1Y Return
56.27%
Buy Reco %
100.00
UPL
PE Ratio
-40.55
1Y Return
34.60%
Buy Reco %
69.57
PE Ratio
279.80
1Y Return
7.59%
Buy Reco %
—
CHAMBLFERT
PE Ratio
18.03
1Y Return
54.02%
Buy Reco %
50.00
BAYERCROP
PE Ratio
29.79
1Y Return
8.18%
Buy Reco %
42.86
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
2024
Current
₹710.90
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹710.90
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
Revenue Forecast
2024
Current
₹463.82
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2024
Current
₹463.82
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
Earnings Per Share Forecast
2024
Current
₹-23.94
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2024
Current
₹-23.94
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 240.19 | 301.53 | 395.02 | 442.06 | 534.54 | 562.79 | 687.04 | 641.23 | 463.82 | 422.41 | ||||||||||
Raw Materials | 160.59 | 179.66 | 224.22 | 295.05 | 333.81 | 344.60 | 444.82 | 460.83 | 318.82 | 474.55 | ||||||||||
| Power & Fuel Cost | 13.84 | 15.75 | 17.87 | 23.80 | 28.80 | 25.28 | 38.04 | 45.68 | 35.87 | |||||||||||
| Employee Cost | 15.89 | 20.38 | 21.71 | 25.10 | 29.92 | 38.35 | 50.31 | 52.26 | 61.74 | |||||||||||
| Selling & Administrative Expenses | 15.62 | 13.65 | 16.74 | 15.41 | 21.83 | 17.17 | 23.55 | 25.77 | 20.97 | |||||||||||
| Operating & Other expenses | -1.38 | 17.44 | 33.43 | -4.93 | 23.07 | 17.92 | -34.22 | -32.63 | 26.69 | |||||||||||
EBITDA | 35.63 | 54.65 | 81.05 | 87.63 | 97.11 | 119.47 | 164.54 | 89.32 | -0.27 | -52.14 | ||||||||||
| Depreciation/Amortization | 10.40 | 13.68 | 14.68 | 19.35 | 23.16 | 25.66 | 34.36 | 33.65 | 36.25 | 41.15 | ||||||||||
| PBIT | 25.23 | 40.97 | 66.37 | 68.28 | 73.95 | 93.81 | 130.18 | 55.67 | -36.52 | -93.29 | ||||||||||
| Interest & Other Items | 12.81 | 12.24 | 10.66 | 12.38 | 12.59 | 4.75 | 9.06 | 20.71 | 25.23 | 32.96 | ||||||||||
| PBT | 12.42 | 28.73 | 55.71 | 55.90 | 61.36 | 89.06 | 121.12 | 34.96 | -61.75 | -126.25 | ||||||||||
| Taxes & Other Items | 7.46 | 9.62 | 20.81 | 20.17 | 13.84 | 24.02 | 31.26 | 9.39 | -14.81 | -6.61 | ||||||||||
| Net Income | 4.96 | 19.11 | 34.90 | 35.73 | 47.52 | 65.04 | 89.86 | 25.57 | -46.94 | -119.64 | ||||||||||
| EPS | 2.55 | 9.81 | 17.88 | 18.29 | 24.29 | 33.22 | 45.86 | 13.04 | -23.94 | -61.01 | ||||||||||
| DPS | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.15 | 0.08 | 0.08 | 0.06 | 0.05 | 0.03 | 0.11 | — | 0.00 |
Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
MaterialsFertilizers & Agro Chemicals
Compare valuation on Screener
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astec Lifesciences Ltd | -29.70 | 3.77 | 0.21% |
| Coromandel International Ltd | 31.38 | 5.45 | 0.34% |
| UPL Ltd | -40.55 | 1.49 | 0.15% |
| Fertilisers And Chemicals Travancore Ltd | 279.80 | 29.73 | 0.15% |
Price Comparison
Compare ASTEC with any stock or ETFCompare ASTEC with any stock or ETF
ASTEC
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
Mutual Funds Holding Trend
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Astec Lifesciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2602% | Percentage of the fund’s portfolio invested in the stock 0.07% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 115/244 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1512% | Percentage of the fund’s portfolio invested in the stock 0.86% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/60 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5509% | Percentage of the fund’s portfolio invested in the stock 0.34% | Change in the portfolio weight of the stock over the last 3 months -0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 38/56 (-2) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ASTEC has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.21%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.11 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 19, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateJul 16, 2020
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 16, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2019
News & Opinions
Articles & Videos
Earnings
Astec Lifesciences reports consolidated net loss of Rs 40.38 crore in the December 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 40.38 crore in the quarter ended December 2024 as against net loss of Rs 24.33 crore during the previous quarter ended December 2023. Sales rose 84.80% to Rs 93.86 crore in the quarter ended December 2024 as against Rs 50.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.8650.79 85 OPM %-6.12-36.09 - PBDT-13.75-23.52 42 PBT-25.15-32.22 22 NP-40.38-24.33 -66 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Astec Lifesciences to table results
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 27 January 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Astec Lifesciences Ltd leads gainers in 'B' group
Avonmore Capital & Management Services Ltd, Spencers Retail Ltd, Jayaswal Neco Industries Ltd and Salasar Techno Engineering Ltd are among the other gainers in the BSE's 'B' group today, 03 January 2025.Astec Lifesciences Ltd spiked 20.00% to Rs 1164.75 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 11933 shares were traded on the counter so far as against the average daily volumes of 774 shares in the past one month. Avonmore Capital & Management Services Ltd surged 19.80% to Rs 23.42. The stock was the second biggest gainer in 'B' group. On the BSE, 33.56 lakh shares were traded on the counter so far as against the average daily volumes of 3.35 lakh shares in the past one month. Spencers Retail Ltd soared 14.31% to Rs 94.8. The stock was the third biggest gainer in 'B' group. On the BSE, 93122 shares were traded on the counter so far as against the average daily volumes of 15676 shares in the past one month. Jayaswal Neco Industries Ltd added 11.08% to Rs 44.42. The stock was the fourth biggest gainer in 'B' group. On the BSE, 1.43 lakh shares were traded on the counter so far as against the average daily volumes of 25963 shares in the past one month. Salasar Techno Engineering Ltd gained 10.27% to Rs 14.07. The stock was the fifth biggest gainer in 'B' group. On the BSE, 35.53 lakh shares were traded on the counter so far as against the average daily volumes of 13.38 lakh shares in the past one month. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 38.56 crore in the September 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 38.56 crore in the quarter ended September 2024 as against net loss of Rs 13.43 crore during the previous quarter ended September 2023. Sales declined 11.05% to Rs 98.55 crore in the quarter ended September 2024 as against Rs 110.79 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales98.55110.79 -11 OPM %-20.03-3.09 - PBDT-27.07-8.44 -221 PBT-38.54-17.60 -119 NP-38.56-13.43 -187 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Astec Lifesciences to hold board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Astec LifeSciences director resigns
Astec LifeSciences announced that Dr. Brahma Nand Vyas has tendered his resignation as an 'Independent Director' of the Company with effect from closure of business hours on 4 October 2024. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Astec Lifesciences announces resignation of Director cum CEO
Astec Lifesciences announced that Anurag Roy has tendered his resignation as the 'Whole Time Director & Chief Executive Officer' of the Company with effect from closure of business hours on 25 October 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Astec Lifesciences appoints director
Astec Lifesciences has appointed Dr. Ganapati Dadasaheb Yadav as a 'Non-Executive & Independent Director' of the Company with effect from 17 September 2024. Powered by Capital Market - Live
5 months agoCapital Market - Live
Astec Lifesciences reports consolidated net loss of Rs 39.72 crore in the June 2024 quarter
7 months agoBusiness Standard
Earnings
Astec Lifesciences reports consolidated net loss of Rs 39.72 crore in the June 2024 quarter
Net Loss of Astec Lifesciences reported to Rs 39.72 crore in the quarter ended June 2024 as against net loss of Rs 8.19 crore during the previous quarter ended June 2023. Sales declined 51.44% to Rs 69.37 crore in the quarter ended June 2024 as against Rs 142.85 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales69.37142.85 -51 OPM %-66.672.19 - PBDT-52.37-1.62 -3133 PBT-61.64-11.01 -460 NP-39.72-8.19 -385 Powered by Capital Market - Live
7 months agoCapital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 0.97%, vs industry avg of 10.41%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.34% to 0.22%